Lisa Henderson retweeted
(4/4) How is your safety monitored in a clinical trial? Watch this short clip and read about this and 9 other key things to know about clinical research: e.lilly/2ScnKFK
Original video via @CISCRP #ICTD202
Lisa Henderson retweeted
Q: What percentage of the world’s researchers are women? @Parexel
Get the answer below! #ICTD2021 #TrialTrivia
Lisa Henderson retweeted
[#CTD2021]
🔬 It’s International Clinical Trials Day!
#ClinicalTrials are a crucial step, and subject to rigorous regulatory controls, to bring forward new therapeutic solutions for #patients.
Lisa Henderson retweeted
We've launched a podcast‼️
Courtney Granville, Global Associate Director, Research and Scientific Programs at @DrugInfoAssn , talks about the options #decentralizedtrials provide, the options for members to learn in a hybrid environment & much more!
🎙️bit.ly/3hGGXug
Lisa Henderson retweeted
🚨Our May issue is LIVE🚨
Maximize your the value of your #remotemonitoring with our cover article🔺Navigate through new changes during the #covid19pandemic 🔺Explore why #RBQM and #centralized monitoring are here to stay & much more!
➡️appliedclinicaltrialsonline.…
#clinicaltrials
Lisa Henderson retweeted
Developing new pathways to overcome study-related challenges is key to realizing the promise of the latest #genetherapies
➡️appliedclinicaltrialsonline.…
#pharma #clinicaltrials #lifesciences #genetherapy #regulatory
Lisa Henderson retweeted
🚨Our April Issue is LIVE🚨
🔷Our annual profile of @HBAnet Woman of the Year🔷 @trialsonline examines #COVID19's ripple effect on #pharma 🔷 &#Pharmaceutical companies that are doubling down on #diversityandinclusion 🔷
➡️files.alfresco.mjh.group/alf…
#genethreapy #clinicaltrials
Lisa Henderson retweeted
Grateful to be able to do the work I do and for this opportunity to share a piece of *my* mind in JAMA this week. @DukeForge @DukeCancer @DukeSurgery @duke_pophealth
@DukeScores @SocietyofBAS @WomenSurgeons #bcsm #ILookLikeASurgeon jamanetwork.com/journals/jam…
Lisa Henderson retweeted
Research Director at Ri, Sven Klingemann, dives into some of his recent work on reputations in the pharmaceutical industry with @PharmExec: bit.ly/34bhVc0
Lisa Henderson retweeted
The issue is risk taking. As the Pelosi bill cuts returns and raises the cost of capital, risk taking in life sciences will decline. We’ll still get new drugs, but we’ll lose the big bets on the highest risk science like gene editing, regenerative medicine statnews.com/2019/11/12/tiny…
Lisa Henderson retweeted
🚨Our November Issue is now LIVE🚨
This month we're talking about the barriers in #precisiononcology 🔺The push for early stage research in #Malaysia 🔺and #China's new era of #researchanddevelopment and #innovation!
All that and more, right here⤵️
files.alfresco.mjh.group/alf…
Lisa Henderson retweeted
🔵Tech Tour for the C-Suite:#Pharma ’s Digital Future🔵
Amid new findings on today’s C-suite mood and approach to digital transformation—explore the intersection of #data &#technology & areas that must evolve to meet the #digitalhealth demands of tomorrow.
ow.ly/AmpO50wHx4B
Lisa Henderson retweeted
Our @bryanomalley talks patients, data, personalized marketing, #digitaltheraputics and more in this @DigitalPharma East article on @PharmExec
bit.ly/2AZMWU4
Lisa Henderson retweeted
Thank you, @trialsonline for including our @bryanomalley in your @PharmExec article! bit.ly/2l2zieJ
#DigitalMarketing
📮Setting Your Launch Path — @trialsonline
There are many factors involved in launching a drug but one prevailing goal: #brandawareness. Bryan O’Malley of @Fingerpainters shares some of today's key #digitaltrends affecting that mission.
ow.ly/6ky550wiamC #pharma
Lisa Henderson retweeted
Start your day with insights from our September issue! #clinicaltrials #pharma #healthcare #clinicalresearch
🚨The September Issue of ACT is now available online!🚨
This month we talk about the changing site landscape of #clinicaltrial sites🔻Championing clinical trial with an Executive Profile of @bmsnews Charlotte Jones-Burton🔻& the #VA gets real on reform!🔻
lnkd.in/eBqU9Yr
Lisa Henderson retweeted
Sounds like a very interesting episode! Learn more about Kris here > janssen.com/kris-sterkens
🚨Episode 40 is now LIVE🚨
Sponsored by @Fingerpainters
🎙bit.ly/2kIpdDL
@JanssenGlobal’s chairman of Europe/Middle East/Africa operations, Kris Sterkens speaks of his #finance background, and challenges for #EMEA #biopharma breaking into the #US market plus much more!
Lisa Henderson retweeted
Interesting finding regarding #wearables in #clinicalresearch.
Replying to @pfizer
@pfizer reports High correlation between wearables and traditional clinical measures to measure scratching in #atopicderm research #mobileclin2019 @LillyTrials
Lisa Henderson retweeted
We love Mei Mei! @puntificating and I had her on the @PharmExec #podcast to talk about deciding to pivot your company. Listen here: pharmexec.com/episode-19-how… #jpm19 #JPMHC19
Mei Mei Hu, CEO of @UNSTechBio, chatting with @the_sy_guy of @FortuneMagazine about pioneering a new class of vaccines that are fully synthetic & train the body to treat and prevent neurological disease.
Learn more: fortune.com/2018/10/03/alzhe… #JPM19 #ChangeTheRatio #WomenInSTEM



























